Q3753947 (Q3753947): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Edited by the infer coords bot - inferring coordiantes from postal codes) |
(Created claim: summary (P836): The project will create a comprehensive knowledge base for stem cell technology in order to enable innovation and business cooperation in the Kuopio region’s bio-sector, especially for the needs identified in the field of health technology, by utilising the University of Eastern Finland’s stem cell expertise, the new stem cell materials it produces, the special expertise of Kuopio Region and Finnish companies focusing on bio-technology and 3D pr...) |
||||||||||||||
Property / summary | |||||||||||||||
The project will create a comprehensive knowledge base for stem cell technology in order to enable innovation and business cooperation in the Kuopio region’s bio-sector, especially for the needs identified in the field of health technology, by utilising the University of Eastern Finland’s stem cell expertise, the new stem cell materials it produces, the special expertise of Kuopio Region and Finnish companies focusing on bio-technology and 3D printing, as well as international networks. The aim is to create new technology platforms and new business opportunities in the province through human-based and personal medicine-based means to develop predictability of brain diseases, prevention, early diagnosis and precision therapies. The project is carried out in collaboration with the University of Helsinki, which has the excellence of microscopic imaging of the living brain, genetic and protein research and the educational experience of the mini-brains. It is difficult to cure brain degenerative diseases because brain diseases develop unnoticed tens of years before the symptoms leading to diagnosis occur, where brain disease has progressed so far that brain changes are already irreversible and drug treatment is no longer effective. It would be possible to effectively prevent brain diseases if they could be predicted already in childhood and to cure the treatments already developed but found to be ineffective if brain disease could be diagnosed and treatment started early enough. The aim of the project is to develop technology to predict, prevent and ultra-early diagnostics of brain disease, which would make it possible to treat the disease. The second objective is to develop technology for the use of human cells as a platform for the development of new medicines and diagnostic methods through stem cell technology, since an animal-based product development platform is a major reason for the failure of product development in drug development. (English) | |||||||||||||||
Property / summary: The project will create a comprehensive knowledge base for stem cell technology in order to enable innovation and business cooperation in the Kuopio region’s bio-sector, especially for the needs identified in the field of health technology, by utilising the University of Eastern Finland’s stem cell expertise, the new stem cell materials it produces, the special expertise of Kuopio Region and Finnish companies focusing on bio-technology and 3D printing, as well as international networks. The aim is to create new technology platforms and new business opportunities in the province through human-based and personal medicine-based means to develop predictability of brain diseases, prevention, early diagnosis and precision therapies. The project is carried out in collaboration with the University of Helsinki, which has the excellence of microscopic imaging of the living brain, genetic and protein research and the educational experience of the mini-brains. It is difficult to cure brain degenerative diseases because brain diseases develop unnoticed tens of years before the symptoms leading to diagnosis occur, where brain disease has progressed so far that brain changes are already irreversible and drug treatment is no longer effective. It would be possible to effectively prevent brain diseases if they could be predicted already in childhood and to cure the treatments already developed but found to be ineffective if brain disease could be diagnosed and treatment started early enough. The aim of the project is to develop technology to predict, prevent and ultra-early diagnostics of brain disease, which would make it possible to treat the disease. The second objective is to develop technology for the use of human cells as a platform for the development of new medicines and diagnostic methods through stem cell technology, since an animal-based product development platform is a major reason for the failure of product development in drug development. (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / summary: The project will create a comprehensive knowledge base for stem cell technology in order to enable innovation and business cooperation in the Kuopio region’s bio-sector, especially for the needs identified in the field of health technology, by utilising the University of Eastern Finland’s stem cell expertise, the new stem cell materials it produces, the special expertise of Kuopio Region and Finnish companies focusing on bio-technology and 3D printing, as well as international networks. The aim is to create new technology platforms and new business opportunities in the province through human-based and personal medicine-based means to develop predictability of brain diseases, prevention, early diagnosis and precision therapies. The project is carried out in collaboration with the University of Helsinki, which has the excellence of microscopic imaging of the living brain, genetic and protein research and the educational experience of the mini-brains. It is difficult to cure brain degenerative diseases because brain diseases develop unnoticed tens of years before the symptoms leading to diagnosis occur, where brain disease has progressed so far that brain changes are already irreversible and drug treatment is no longer effective. It would be possible to effectively prevent brain diseases if they could be predicted already in childhood and to cure the treatments already developed but found to be ineffective if brain disease could be diagnosed and treatment started early enough. The aim of the project is to develop technology to predict, prevent and ultra-early diagnostics of brain disease, which would make it possible to treat the disease. The second objective is to develop technology for the use of human cells as a platform for the development of new medicines and diagnostic methods through stem cell technology, since an animal-based product development platform is a major reason for the failure of product development in drug development. (English) / qualifier | |||||||||||||||
point in time: 23 November 2021
|
Revision as of 03:22, 23 November 2021
Project Q3753947 in France
Language | Label | Description | Also known as |
---|---|---|---|
English | No label defined |
Project Q3753947 in France |
Statements
252,000 Euro
0 references
281,020.0 Euro
0 references
89.67 percent
0 references
1 December 2019
0 references
31 March 2022
0 references
Helsingin Yliopisto
0 references
00290
0 references
Hankkeessa luodaan kattava kantasoluteknologian osaamisperusta innovaatiotoiminnan ja yritysyhteistyön mahdollistamiseksi Kuopion seudun bioalalla, erityisesti terveysteknologian alalla tunnistettuihin tarpeisiin hyödyntämällä Itä-Suomen yliopiston kantasoluosaamista, sen valmistamia uusia kantasolumateriaaleja, Kuopion seudun ja suomalaisten bio-alan ja 3D-tulostukseen keskittyneiden yritysten erityisosaamista, sekä kansainvälisiä verkostoja. Tavoitteena on luoda maakuntaan uusia teknologia-alustoja ja uusia liiketoimintamahdollisuuksia ihmispohjaisilla ja henkilökohtaiseen lääketieteeseen nojaavilla keinoilla aivosairauksien ennustettavuuden, prevention, varhaisen diagnoosin ja täsmähoitojen kehittämiseksi.Hanke tehdään yhteistyössä Helsingin yliopiston kanssa, jossa on elävän aivon mikroskooppisen kuvantamisen ja geeni- sekä proteiinitutkimuksen huippuosaamista ja miniaivojen kasvatuskokemusta. Aivojen rappeumasairauksien parantaminen on vaikeaa, koska aivosairaudet kehittyvät huomaamatta kymmenien vuosia ennen diagnoosiin johtavia oireita, joiden ilmetessä aivosairaus on edennyt niin pitkälle, että aivomuutokset ovat jo peruuttamattomia eikä lääkehoito enää tehoaa. Aivosairauksia olisi mahdollista ehkäistä tehokkaasti, mikäli ne voitaisiin ennustaa jo lapsuudessa, ja parantaa jo kehitetyillä mutta toistaiseksi tehottomaksi todetuilla hoidoilla, mikäli aivosairaus voitaisiin diagnosoida ja hoito aloittaa riittävän varhain. Hankkeen tavoite on kehittää teknologiaa aivosairauden ennustamiseksi, ehkäisemiseksi ja ultravarhain diagnostisoitavaksi, jolloin sairaus olisi mahdollista hoitaa. Toinen tavoite on kehittää teknologiaa ihmisen solujen käyttämiseksi uusien lääkkeiden ja diagnostiikkamenetelmien kehitysalustana kantasoluteknologian avulla, sillä eläinpohjainen tuotekehitysalusta on suuri syy tuotekehityksen epäonnistumiselle lääkekehityksessä. (Finnish)
0 references
The project will create a comprehensive knowledge base for stem cell technology in order to enable innovation and business cooperation in the Kuopio region’s bio-sector, especially for the needs identified in the field of health technology, by utilising the University of Eastern Finland’s stem cell expertise, the new stem cell materials it produces, the special expertise of Kuopio Region and Finnish companies focusing on bio-technology and 3D printing, as well as international networks. The aim is to create new technology platforms and new business opportunities in the province through human-based and personal medicine-based means to develop predictability of brain diseases, prevention, early diagnosis and precision therapies. The project is carried out in collaboration with the University of Helsinki, which has the excellence of microscopic imaging of the living brain, genetic and protein research and the educational experience of the mini-brains. It is difficult to cure brain degenerative diseases because brain diseases develop unnoticed tens of years before the symptoms leading to diagnosis occur, where brain disease has progressed so far that brain changes are already irreversible and drug treatment is no longer effective. It would be possible to effectively prevent brain diseases if they could be predicted already in childhood and to cure the treatments already developed but found to be ineffective if brain disease could be diagnosed and treatment started early enough. The aim of the project is to develop technology to predict, prevent and ultra-early diagnostics of brain disease, which would make it possible to treat the disease. The second objective is to develop technology for the use of human cells as a platform for the development of new medicines and diagnostic methods through stem cell technology, since an animal-based product development platform is a major reason for the failure of product development in drug development. (English)
23 November 2021
0 references